PRIMARY OUTCOME MEASURES
To evaluate sensitivity and specificity of PET/CT imaging with TLX250-CDx to non-invasively detect ccRCC in patients with indeterminate renal masses, using histology as standard of truth.
This outcome will be evaluated on all patients by using a PET/CT machine to determine the uptake of the Zr89 radiotracer within the renal lesion. This will be compared against the histological determination of the lesion type following resection of the lesion.
For more information on the ZIRCON study see: https://clinicaltrials.gov/ct2/show/NCT03849118